Hassan M Yaish MD

PubMed

• 3 citations
  Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand Disease
  Michelle Sholzberg, Kate Khair, Hassan M. Yaish, George M. Rodgers, Maria Sol Cruz
  TH Open. 2021-07-01
• 11 citations
  Pyruvate kinase deficiency in children.
  Satheesh Chonat, Stefan W. Eber, Susanne Holzhauer, Nina Kollmar, D. Holmes Morton
  Pediatric Blood & Cancer. 2021-06-14
• 22 citations
  Comorbidities and complications in adults with pyruvate kinase deficiency.
  Audra N. Boscoe, Yan Yan, Elizabeth Hedgeman, Eduard J. van Beers, Hanny Al-Samkari
  European Journal of Haematology. 2021-01-24

Abstracts/Posters

• Comorbidities and Complications in Adults with Pyruvate Kinase Deficiency
  Hassan M. Yaish, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Characterization of the Severe Phenotype of Pyruvate Kinase Deficiency
  Hassan M. Yaish, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study
  Hassan M. Yaish, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Final Results from a Non-Interventional Safety and Efficacy Study of a VWF/FVIII Concentrate (wilate®) in Patients with Von Willebrand Disease 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018